BIO-key International, Inc., together with its subsidiaries, develops and markets fingerprint identification biometric technology, enterprise-ready identity access management solutions, and software solutions to commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premise SaaS application, as well as windows device authentication through IAM platform. Its solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative. In addition, it provides BIO-key VST and WEB-key products; and Civil and Large-Scale ID Infrastructure solutions develops finger-based biometric technology. Further, it offers finger scanners for enterprise and consumer markets under SideSwipe, EcoID, and SidePass brand names. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey.
IPO Year:
Exchange: NASDAQ
Website: bio-key.com
DENVER and HOMDEL, N.J., Dec. 11, 2023 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of Identity and Access Management (IAM) solutions including Identity-Bound Biometrics, and Ping Identity, a leading provider of seamless and secure digital experiences, announced today that BIO-key's unique biometric authentication technology is now included on the Ping Identity Integration Directory. The integration enables Ping clients to utilize BIO-key's powerful and seamless biometric authentication solution in combination with the PingOne Cloud Platform. The combined solution streamlines authentication processes and ensures a secure, frictionless user experien
WALL, N.J., June 02, 2023 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB), today announced that it has appointed Cameron E. Williams to its Board of Directors. Mr. Williams has spent over forty years in leading executive officer roles in banking and financial services firms, serving on the board of directors of multiple organizations and more recently, in founding and leading strategic, financial and security consulting firms. Mr. Williams brings deep experience, an ideal skill set, and a broad base of relationships to his role on BIO-key
WALL, N.J., Jan. 03, 2023 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), an innovative provider of Identity and Access Management (IAM) and Identity-Bound Biometric (IBB) solutions, today announced the appointment of Galen Rodgers, Vice President of Channels, and Chad Carter, VP North America Sales. The appointments are effective today, January 3, and are in anticipation of the planned retirement of Chief Revenue Officer Fred Corsentino. A top-performing technology leader, Galen Rodgers, who will report to Chairman & CEO Michael DePasquale, brings 20+ years of experience in channel program development, marketing strategy, value selling, management, cyber security, proces
S-1 - BIO KEY INTERNATIONAL INC (0001019034) (Filer)
8-K - BIO KEY INTERNATIONAL INC (0001019034) (Filer)
10-K - BIO KEY INTERNATIONAL INC (0001019034) (Filer)
NT 10-K - BIO KEY INTERNATIONAL INC (0001019034) (Filer)
8-K - BIO KEY INTERNATIONAL INC (0001019034) (Filer)
8-K - BIO KEY INTERNATIONAL INC (0001019034) (Filer)
8-K - BIO KEY INTERNATIONAL INC (0001019034) (Filer)
8-K - BIO KEY INTERNATIONAL INC (0001019034) (Filer)
10-Q - BIO KEY INTERNATIONAL INC (0001019034) (Filer)
424B3 - BIO KEY INTERNATIONAL INC (0001019034) (Filer)
HOLMDEL, N.J. , April 24, 2025 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication, announced today that on April 17, 2025, it received a notification letter from The Nasdaq Stock Market, LLC informing the Company that it was not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission, due to the Company's failure to timely file its Annual Report on Form 10-K for the
LISBON, Portugal and HOLMDEL, N.J., March 31, 2025 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) software for phoneless, tokenless, passwordless, and phishing-resistant authentication experiences, today announced a strategic partnership with Arrow ECS Iberia, a leading cybersecurity and enterprise IT solutions, value-added distributor in Spain and Portugal. Through this collaboration, Arrow ECS Iberia joins BIO-key's Channel Alliance Partner program, expanding the availability of BIO-key's cutting-edge IAM solutions across the Iberian market. With the increasing demand for robust, regul
HOLMDEL, N.J., March 27, 2025 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication, announced results for its fourth quarter (Q4'24) and year ended December 31, 2024 (2024). BIO-key's 2023 results, which were restated and filed with the Company's 2023 Form 10-K, are reflected in this release for comparison purposes. BIO-key will host an investor call today, Thursday, March 27th at 10:00am ET (details below). BIO-key CEO, Mike DePasquale commented, "From a strategic sta
MADRID, Spain and HOLMDEL, N.J., March 26, 2025 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication solutions has successfully completed the deployment of a comprehensive suite of BIO-key biometric-based IAM solutions for a new International Defense Agency customer. The full deployment for the initial sites was completed in just four days, showcasing the efficiency, seamless integration, and collaboration between BIO-key and the customer's IT team. The deployment incorporates these BIO-key solutions: PortalGuard On-Prem – A highly secure IAM platform providing Multi-factor Authentication (MFA
HOLMDEL, N.J., March 20, 2025 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), an innovative provider of Identity and Access Management and Identity-Bound Biometric solutions, will host its Q4 2024 investor call Thursday, March 27th at 10 a.m. ET. Results will be released before the market opens on Thursday. Mike DePasquale, Chairman & CEO and Cecilia Welch, CFO will lead the conference call and Q&A session. Conference Call Details Date / Time:Thursday, March 27th at 10 a.m. ETCall Dial In #:1-877-418-5460 U.S. or 1-412-717-9594 Int'lLive Webcast / Replay:Webcast & Replay Link – Available for 3 months.Audio Replay:1-877-344-7529 U.S. or 1-412-317-0088 Int'l; code 674731
- BIO-key's PortalGuard Solution Delivers SecureMulti-Factor Authentication without Requiring Phones or Tokens - FRESNO, Calif. and HOLMDEL, N.J., March 13, 2025 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) software for phoneless, tokenless, passwordless, and phishing-resistant authentication experiences, announced today a new partnership and Joint Purchase Agreement (JPA) with California's Education Technology Joint Powers Authority (Ed Tech JPA), an alliance of 195 K-12 schools and school districts serving over 2.6 million students. BIO-key's PortalGuard Platform was accepted as an
HOLMDEL, N.J., Jan. 27, 2025 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) software for phoneless, tokenless, passwordless, and phishing-resistant authentication experiences, announced today that the State of Wyoming Department of Education (WDE) has awarded BIO-key a contract to implement its PortalGuard IDaaS platform for up to 20,000 staff members. This solution will enhance the WDE's security posture and improve the user experience by providing both Multi-Factor Authentication (MFA) and Single Sign-On (SSO) access to digital resources and applications. The agency sought a comprehens
HOLMDEL, N.J., Jan. 21, 2025 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) software for phoneless, tokenless, passwordless, and phishing-resistant authentication, announced today that three additional customers: Northeast Iowa Community College – Peosta, IA;Eastern University – St. Davids, PA; and University of Guam – Mangilao, Guam, with over 30,000 users, have migrated their on-premises deployments of PortalGuard to the PortalGuard IDaaS enterprise security platform. These customers join over 50 organizations with 4+ million users that have embraced BIO-key's cloud-based solu
CAIRO, Egypt and HOLMDEL, N.J., Jan. 15, 2025 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of Identity and Access Management (IAM) solutions featuring multi-factor authentication (MFA) and Single Sign-On (SSO) technologies, announced today that the National Bank of Egypt (NBE), Egypt's largest financial institution, is deploying BIO-key's PortalGuard identity and access management platform and an industry-leading Identity Governance solution. This strategic project is being implemented in partnership with Raya Information Technology, a trusted reseller certified in BIO-key technologies, as part of NBE's ongoing efforts to deploy best-in-class IT so
ATLANTIC CITY, NJ and HOLMDEL, NJ / ACCESSWIRE / January 10, 2025 / BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB) for phoneless, tokenless, passwordless, and phish-resistant authentication, will present and meet with investors at DealFlow Event's Microcap Conference on Wednesday, January 29th & 30th at the Borgata hotel in Atlantic City, New Jersey.CEO Mike DePasquale will present at 2:00pm ET on Wednesday and be available for meetings both days.Registration Information:Click here: https://themicrocapconference.com/tickets/ to register and attend the Microcap Conference. Qualified
SC 13G/A - BIO KEY INTERNATIONAL INC (0001019034) (Subject)
SC 13G - BIO KEY INTERNATIONAL INC (0001019034) (Subject)
SC 13G/A - BIO KEY INTERNATIONAL INC (0001019034) (Subject)
SC 13G/A - BIO KEY INTERNATIONAL INC (0001019034) (Subject)
SC 13G - BIO KEY INTERNATIONAL INC (0001019034) (Subject)
SC 13G/A - BIO KEY INTERNATIONAL INC (0001019034) (Subject)
SC 13G/A - BIO KEY INTERNATIONAL INC (0001019034) (Subject)
HOLMDEL, N.J., March 27, 2025 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication, announced results for its fourth quarter (Q4'24) and year ended December 31, 2024 (2024). BIO-key's 2023 results, which were restated and filed with the Company's 2023 Form 10-K, are reflected in this release for comparison purposes. BIO-key will host an investor call today, Thursday, March 27th at 10:00am ET (details below). BIO-key CEO, Mike DePasquale commented, "From a strategic sta
HOLMDEL, N.J., March 20, 2025 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), an innovative provider of Identity and Access Management and Identity-Bound Biometric solutions, will host its Q4 2024 investor call Thursday, March 27th at 10 a.m. ET. Results will be released before the market opens on Thursday. Mike DePasquale, Chairman & CEO and Cecilia Welch, CFO will lead the conference call and Q&A session. Conference Call Details Date / Time:Thursday, March 27th at 10 a.m. ETCall Dial In #:1-877-418-5460 U.S. or 1-412-717-9594 Int'lLive Webcast / Replay:Webcast & Replay Link – Available for 3 months.Audio Replay:1-877-344-7529 U.S. or 1-412-317-0088 Int'l; code 674731
HOLMDEL, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication, announced results for its third quarter ended September 30, 2024 (Q3'24). BIO-key's 2023 Q3 and nine month results were restated and filed with the Company's 2023 Form 10-K and are reflected in this release. BIO-key will host an investor call tomorrow, Friday, November 15th at 10:00am ET (details below). Financial Highlights Q3'24 revenues rose 18% to $2.1M from $1.8M in Q3'23, principally du
HOLMDEL, N.J., Nov. 07, 2024 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), an innovative provider of Identity and Access Management and Identity-Bound Biometric solutions, will host its Q3 2024 investor call Friday, November 15th at 10 a.m. ET. Results will be released after the market close on Thursday. Mike DePasquale, Chairman & CEO and Cecilia Welch, CFO will lead the conference call and Q&A session. Conference DetailsDate / Time: Friday, November 15th at 10 a.m. ETCall Dial In #: 1-877-418-5460 U.S. or 1-412-717-9594 Int'lLive Webcast / Replay: Webcast & Replay Link – Available for 3 months.Audio Replay: 1-877-344-7529 U.S. or 1-412-317-0088 Int'l; code 7307131 Ab
HOLMDEL, N.J., Aug. 14, 2024 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication, announced results for its second quarter ended June 30, 2024 (Q2'24). Note, BIO-key's results for 2023 were restated at year-end and filed with the Company's 2023 Form 10-K, and as a result Q2'23 and six months ended June 30, 2023 comparisons in this release have been restated. BIO-key will host an investor call Thursday, August 15th at 10:00am ET (details below). Financial Highlights Q2'24 revenues decrease
HOLMDEL, N.J., Aug. 12, 2024 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), an innovative provider of Identity and Access Management and Identity-Bound Biometric solutions, will host its Q2 2024 investor call Thursday, August 15th at 10 a.m. ET. Results will be released after markets close on Wednesday. Mike DePasquale, Chairman & CEO and Cecilia Welch, CFO will lead the conference and Q&A session. Conference Call DetailsDate / Time:Thursday, August 15th at 10 a.m. ETCall Dial In #:1-877-418-5460 U.S. or 1-412-717-9594 Int'lLive Webcast / Replay:Webcast & Replay Link – Available for 3 months.Audio Replay:1-877-344-7529 U.S. or 1-412-317-0088 Int'l; code 7767803 About BIO-
HOLMDEL, N.J., June 17, 2024 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication, announced results for its first quarter ended March 31, 2024 (Q1'24). Note, BIO-key's results for the first three quarters of 2023 were restated at year-end and filed with the Company's 2023 Form 10-K, and as a result Q1'23 comparisons in this release have been restated. BIO-key will host an investor call Tuesday, June 18th at 10:00am ET (details below). Q1 Financial Highlights Q1'24 revenues of $2.2M were i
HOLMDEL, N.J., June 13, 2024 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), an innovative provider of Identity and Access Management and Identity-Bound Biometric solutions, will host its Q1 2024 investor call Tuesday, June 18th at 10 a.m. ET. Results will be released prior to the call. Mike DePasquale, Chairman & CEO and Cecilia Welch, CFO will lead the conference and Q&A session. Conference Call Details Date / Time: Tuesday, June 18th at 10 a.m. ETCall Dial In #: 1-877-418-5460 U.S. or 1-412-717-9594 Int'lLive Webcast / Replay: Webcast & Replay Link – Available for 3 months.Audio Replay: 1-877-344-7529 U.S. or 1-412-317-0088 Int'l; code 1988012 BIO-key at a
HOLMDEL, N.J., April 01, 2024 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication, announced preliminary results for its fourth quarter (Q4'23) and year ended December 31, 2023 (2023). The independent audit of BIO-key's 2023 financial statements has not yet been completed and, therefore, the figures included herein are subject to change. BIO-key will host an investor call tomorrow at 10:00am ET (details below). Preliminary Results Highlights: 2023 revenue rose $2M (29%) to $9.1M2023 S
HOLMDEL, N.J., March 27, 2024 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), an innovative provider of Identity and Access Management and Identity-Bound Biometric solutions, will host its Q4 2023 investor call Tuesday, April 2nd at 10 a.m. ET. Results will be released after the market close on Monday. Mike DePasquale, Chairman & CEO and Cecilia Welch, CFO will lead the call and Q&A session. Conference Call Details Date / Time: Tuesday, April 2nd at 10 a.m. ETCall Dial In #:1-877-418-5460 U.S. or 1-412-717-9594 Int'lLive Webcast / Replay:Webcast & Replay Link – Available for 3 months.Audio Replay:1-877-344-7529 U.S. or 1-412-317-0088 Int'l; code 6114035 BIO-key at a G
4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)
4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)
4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)
4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)
4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)
3 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)
4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)
4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)
4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)
4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)
Maxim Group upgraded Bio-key from Hold to Buy and set a new price target of $6.00
4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)
4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)
4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)
4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)
4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)